VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 25, 2014) -Verisante Technology, Inc. (TSX VENTURE:VRS)(OTCQX:VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, today announced that Thomas Braun, President & CEO will present at the upcoming 2nd Global Life Sciences Conference in Warsaw on October 2, 2014 at the trading floor of the Warsaw Stock Exchange, Warsaw, Poland.
Warsaw, the financial capital of Central and Eastern Europe, is a major center of life science investment. On October 2nd, at the Global Life Sciences Conference, over 100 leading life science institutional investors, fund managers and analysts from Central and Eastern Europe will gather in Warsaw to discuss and assess new investment opportunities. They will have access there to Verisante's management through a corporate presentation and small group meetings.
The organizers of this event are: WDM Capital, Wedbush Europe and the Filipex Enterprises. The partners of this event are: Warsaw Stock Exchange, Wedbush, Wierzbowski Eversheds and Crescendo Communications. For more information please visit: https://lscwarsaw.com
The Company also announced that effective immediately, Joe Biegel has resigned from the Board of Directors and Dr. Branko Palcic has been appointed to the Board.